COMPANY

Quince Therapeutics

Keywords: respiratory inhaled

Location: New Haven, CT · source · Oct 14, 2026

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

2026-06-11 Raise Private raise (SEC Form D): $114.7M sold of $186.4M offered; issuer “Quince Therapeutics, Inc.”. Verified from the SEC filing. SEC filing ↗
2026-06-11 Raise Private raise (SEC Form D): amount sold not stated; issuer “Quince Therapeutics, Inc.”. Verified from the SEC filing. SEC filing ↗
2025-07-01 Raise Private raise (SEC Form D): $11.5M sold of $21.9M offered; issuer “Quince Therapeutics, Inc.”. Verified from the SEC filing. SEC filing ↗

SEC Form D raise Raised $114.72M (Form D filed Jun 11, 2026). SEC Form D 0000912282-26-000809 (Jun 11, 2026)
Evidence (1 event)
- Jun 11, 2026 · SEC Form D 0000912282-26-000809
  Name of Issuer: Quince Therapeutics, Inc.; CIK: 1662774; Address: South San Francisco, CA; Submission type: D; Filing date: 2026-06-11; Industry Group: Biotechnology; Date of First Sale: 2026-05-18; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 186422679; Total Amount Sold: 114720542; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals